ICM
PATH icon

Invenomic Capital Management’s UiPath PATH Stock Holding History

Invenomic Capital Management’s Portfolio PATH Stock Details PATH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$19.4M Buy
1,787,590
+150,688
+9% +$1.61M 1.16% 31
2026
Q1 		$18.2M Buy
1,636,902
+973,468
+147% +$12.4M 0.83% 46
2025
Q4 		$10.9M Sell
663,434
-434,705
-40% -$6.77M 0.51% 66
2025
Q3 		$14.7M Buy
+1,098,139
New +$13M 0.71% 49
2025
Q2 		– Sell
-528,839
Closed -$5.45M – 184
2025
Q1 		$5.45M Buy
528,839
+168,690
+47% +$2.17M 0.28% 109
2024
Q4 		$4.58M Buy
360,149
+5,027
+1% +$66.4K 0.22% 113
2024
Q3 		$4.55M Buy
+355,122
New +$4.35M 0.25% 105

Other funds holding PATH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TAM
TFG Asset Management Grand Cayman, Cayman Islands $635M AUM 28.07% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
SM
Senvest Management New York $3.41B AUM 66.27% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Invenomic Capital Management's PATH Position: Q2 2026 in Review

Invenomic Capital Management increased its UiPath (PATH) stake by 9.2% in Q2 2026, buying an estimated $1.61M and bringing the position to 1,787,590 shares worth $19.4M. The position accounts for 1.16% of the portfolio, ranked #31.

Invenomic Capital Management first reported a position in PATH in Q3 2024 and has held it in 7 quarters since. 529 funds tracked by Wall St. Rank hold PATH as of Q2 2026.

  • Invenomic Capital Management held 1,787,590 shares of UiPath worth $19.4M as of Q2 2026.
  • Invenomic Capital Management bought 150,688 UiPath shares in Q2 2026, an estimated $1.61M.
  • UiPath made up 1.16% of Invenomic Capital Management's portfolio in Q2 2026, its #31 holding.
  • Invenomic Capital Management first reported a position in UiPath in Q3 2024 and has held it in 7 quarters since.
  • 529 funds tracked by Wall St. Rank held UiPath as of Q2 2026.

Based on Invenomic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.